Delenex Therapeutics Company
Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company's fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically validated technology delivers antibodies exhibiting the highest affinity, solubility and stability all combined with a very low risk of immunogenicity.
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2009-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41 44 730 51 80
Investors:
BioMedPartners, HBM Healthcare Investments, Novo Holdings, SV Health Investors, VI Partners
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Dominik Escher